Skip to main content
. 2021 Mar 31;11(3):e040465. doi: 10.1136/bmjopen-2020-040465

Figure 3.

Figure 3

Forrest plot of the result of univariate analysis regarding the association of the tire of anti-cyclic citrullinated peptide (CCP) antibody with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). The results of univariate analyses in 12 studies were pooled for meta-analysis. The titre of anti-CCP antibody was significantly higher for RA-ILD than RA without ILD with a standardised mean difference (SMD) of 0.42 (95% CI: 0.20 to 0.65, p=0.0002/95% prediction interval: −0.33 to 1.17). There was considerable heterogeneity (χ2=36.0, p=0.0002, I2=69%).